Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/DRKS00022436
DRKS00022436RecruitingNot Applicable

Prospective observational study to investigate demography, clinical course and biomarkers of progressive supranuclear palsy. - ProPSP

Klinikum rechts der Isar der TU München0 sites1,000 target enrollmentStarted: August 4, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,000
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
40 Years to one (—)
Sex
All

Inclusion Criteria

  • •Clinical diagnosis of suggestive of, possible or probable PSP according to the MDS-PSP diagnostic criteria (Höglinger et al., 2017)

Exclusion Criteria

  • •Exclusion criteria are equivalent to the MDS.PSP diagnostic criteria

Investigators

Sponsor
Klinikum rechts der Isar der TU München

Similar Trials

Recruiting
Not Applicable
Prospective observational study to investigate the long-term course of MR-guided percutaneous tumor ablation of primary or secondary liver or kidney tumorsC22C64Malignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of kidney, except renal pelvis
DRKS00026171niversitätsklinikum Tübingen300
Completed
Not Applicable
Study to investigate the feasibility of layer to layer suturing for artificial ulcers after endoscopic resection of gastrointestinal tumorsGastrointestinal tumors
JPRN-UMIN000046388Keio University30
Completed
Not Applicable
Prospective observational study to investigate the predictors of trastuzumab induced cardiac toxicity in breast cancer patients with perioperative chemotherapybreast cancer
JPRN-UMIN000016962Graduate School of Medicine Kyoto University50
Not yet recruiting
Not Applicable
Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis.Rheumatoid arthritis
JPRN-UMIN000048381Department of Hospital Pharmacy, Hamamatsu University School of Medicine100
Not yet recruiting
Not Applicable
Prospective observational study to investigate the health benefits of the smartphone application hiPanyaSleep problems (to be distinguished from sleep disorders as defined by the inclusion and exclusion criteria of this study)
DRKS00034323Medigital GmbH98